SCHEMBL14950940

SCHEMBL14950940

COc1ccc(C2CC(=O)C3=C(C2)Nc2ccccc2N(C(=O)OCC(C)C)C3c2ccc(N(C(C)C)C(C)C)cc2OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 3/20 0.52
MEN1 O00255 6/20 0.51
MAPK1 P28482 2/20 0.48
HSD17B10 Q99714 4/20 0.44
GAA P10253 5/20 0.39
GLA P06280 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.38
USP2 O75604 1/20 0.38
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14941744 0.92 ALDH1A1 (0.55) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14941828 0.92 KDM4E (0.52) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14941546 0.91 ALDH1A1 (0.54) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14950966 0.90 ALDH1A1 (0.64) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14940581 0.90 ALDH1A1 (0.56) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14941540 0.89 ALDH1A1 (0.53) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14941544 0.86 ALDH1A1 (0.51) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14950799 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14940628 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EMEN1MAPK1HSD17B10
SCHEMBL14941709 0.85 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013068592-A1 INHIBITORS OF CYSTATHIONINE BETA SYNTHASE TO REDUCE THE NEUROTOXIC OVERPRODUCTION OF ENDOGENOUS HYDROGEN SULFIDE FONDATION JEROME LEJEUNE (FR) 2013-05-16 WO disclosed